These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 672167)

  • 41. [Changes in the liver in acute cholecystopancreatitis].
    Mikeladze KD; Ginzburg IE
    Khirurgiia (Mosk); 1969 Mar; 45(3):70-3. PubMed ID: 5375956
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies on duodenal cyclic AMP content content in pancreatic disease after administration of pancreozymin and secretin.
    Matsumoto R; Arima T; Tsunashima T; Kawai K; Suwaki K; Tanigawa T; Kita S; Nagashima H
    Am J Gastroenterol; 1980 Aug; 74(2):138-42. PubMed ID: 6255794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of cholecystokinin-pancreozymin on active and passive sugar absorption in the small intestine of the rat].
    Rommel K; Böhmer R; Hotz H
    Z Gastroenterol; 1972; 10(4):277-82. PubMed ID: 4677235
    [No Abstract]   [Full Text] [Related]  

  • 44. Hepatic aberrations in patients with chronic pancreatitis.
    Haboubi NY; Ali HH; Braganza JM
    Gut; 1992 Nov; 33(11):1581-2. PubMed ID: 1452088
    [No Abstract]   [Full Text] [Related]  

  • 45. [The effect of dopamine on liver circulation in man].
    Shimazu M; Aoki H; Mita S; Miyakita M
    Nihon Shokakibyo Gakkai Zasshi; 1986 Jun; 83(6):1153-60. PubMed ID: 3761684
    [No Abstract]   [Full Text] [Related]  

  • 46. [The substructure of the liver cell under hormonal and toxic stimulation].
    POHL W
    Z Gesamte Inn Med; 1962 Mar; 17():199-203. PubMed ID: 14487416
    [No Abstract]   [Full Text] [Related]  

  • 47. On Absorption without Circulation.
    Lautenbach BF
    J Physiol; 1879 Jul; 2(2):110-2. PubMed ID: 16991277
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of pharmacologic preparations on hepatic blood flow studied by tetrapolar rheo-hepatography].
    Geller LI; Petrenko VF; Griaznova MV; Bessonova GA
    Ter Arkh; 1988; 60(8):77-9. PubMed ID: 3227483
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacometabolic capacity of the liver and the effect of pancreozymin in chronic hepatitis, chronic pancreatitis and diabetes mellitus].
    Geller LI; Griaznova MV; Bulgakova OS; Kozlova ZP
    Ter Arkh; 1982; 54(2):67-9. PubMed ID: 7071776
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of pancreozymin on insulin secretion in experimental chronic pancreatitis].
    Vladimirov VG; Podotykina OI; Zhuravlev AG
    Patol Fiziol Eksp Ter; 1986; (3):56-8. PubMed ID: 3529010
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of secretin and pancreozymin on pancreatico-duodenal lymph flow and lipase activity in normal dogs and on thoracic duct lymph flow and lipase activity in rats with chronic pancreatitis.
    Papp M; Ormai S; Horvăth EJ; Fodor I
    Lymphology; 1971 Sep; 4(3):67-73. PubMed ID: 5098885
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of pancreozymin on the absorptive capacity of the hepatocytes and liver circulation in chronic recurrent pancreatitis].
    Geller LI; Bulgakova OS; Petrenko VF
    Klin Med (Mosk); 1978 Jun; 56(6):72-6. PubMed ID: 672167
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.